Product sales of branded drugs chop down by 1.4% within 2014, while generics increased by 9.
5% Bayer pharmaceuticals invested more as compared to four billion eurosin research and development in oncology, ophthalmology, women's health, cardiology and hematology in Asian America.
how to become a rep
According to Laura González-Molero, president of Bayer HealthCare Pharmaceuticals Latin America division, half of which is committed to research in order to pharmaceutical division will end up being allocated in order to speed time-phases of advancement, approval and registration of new molecules.
There are usually five therapeutic areas in which Bayer will target its research efforts, these oncology, ophthalmology, women's health, cardiology and hematology.
Inside Bayer are determined to be able to continue our commitment to innovation and launch brand-new molecules in Latin The united states still meet unmet needs, "stated the president.
I highly recommend you go to my website: how to be a pharmaceutical rep to place you in the spped track and to finally get your splendid job.
Within addition, González-Molero has outlined the "successful" balance sheet regarding the company in typically the region in fiscal 2014, with 42.
2 billion dollars euros in sales plus an increase of seven.
2% over the previous year.
The market for prescription drugs (basically consists associated with branded drugs, with or without particular in force) in Spain in 2014 fell 1 .
4% while sales of universal products during this period of time grew by 9.
five per cent as recorded Bulletin Medications Market Situation in The country number 118 which compiles monthly the pharmaceutical industry.
These data show typically the duality in which is usually immersed, both public and private Spanish pharmaceutical market, with significant growth in revenue of generic and sharp declines in sales of patented medicines.
This circumstance, which marked the general trend a year ago, is not necessarily expected very different within 2015, as have expected the leading industry industry analysts.
The Bulletin is also collects the generic marketplace price represents almost 80 percent of the prescription drug market in Spain (78.
3%), and 47.
Additionally please join in the facebook page: how to get a job in pharmaceutical sales and the linkedin page: how to become a pharmaceutical sales rep 9% in the market in investments, having experienced growth very essential in recent years.
Only two years ago, in 2012, the market industry share of generic drugs price has been 67.
1% in models and 39.
6% in value, implying an enhance of the market reveal of these drugs 17% in units and 21% found in value in just a couple of years.
On the additional hand, the Bulletin investigates the regional pharmaceutical industry last year, showing typically the dispersion of public pharmaceutic expenditure per capita, starting from 268 euros per person in Extremadura to 163 euros de Baleares, with out regard to the autonomous cities of Ceuta and Melilla.
This dispersion has been reduced in The country of spain last year, since the coefficient of variation has risen from 13.
2% in 2013 to twelve.
7% in 2014.
In accordance to available data, 1 of the most essential variables that make typically the pharmaceutical expenditure per capita, as in the case associated with prescriptions per capita intake, differs both between different regions is the various degree of aging human population